46 results
Page 3 of 3
8-K
EX-99.1
7ypyn kln6yg9k
7 Nov 07
DYNAVAX and MERCK & CO., INC. ANNOUNCE PARTNERSHIP TO DEVELOP HEPLISAV™, AN INVESTIGATIONAL HEPATITIS B VACCINE CURRENTLY IN PHASE 3
12:00am
8-K
EX-99.1
b6jamn
1 May 06
Dynavax Announces First Quarter 2006 Financial Results and Outlook
12:00am
8-K
EX-99.1
i1dt0krx v5qzz
15 Mar 06
Dynavax Announces Fourth Quarter and Year-end 2005 Financial Results
12:00am
8-K
EX-99.1
2gs bew68uqchs
19 Aug 05
Dynavax Appoints Acclaimed Vaccine Pioneer DR. Stanley A. Plotkin to Board of Directors
12:00am
8-K
EX-99.1
kvnejm68403fe9q
5 Jan 05
Dynavax Appoints Deborah A. Smeltzer As Chief Financial Officer
12:00am
S-1
lctsinw12gyx89puzo
5 Dec 00
IPO registration
12:00am